South Korea developing bioweapon defenses

According to South Korea's defense minister, the country is researching and developing defensive measures against possible biological and chemical attacks from North Korea.
During an annual parliamentary audit, Kim Kwan-jin, the country's defense minister, said that while South Korea does not yet have vaccines against those types of offenses, they will be put in place soon, Yonhap News Agency reports.
"Since the project costs a lot of money, we haven't settled on the exact date on when we can develop vaccines," Kim said, according to Yonhap News Agency. "But once they're developed, there should be no major problem."
Kim said that U.S. forces in Korea have vaccines against anthrax and that South Korean health authorities have similar vaccines and the capability of developing thier own vaccines.
Han Min-koo, the chairman of the joint chiefs of staff, said that U.S. troops and South Korea have engaged in joint identification and detection exercises and will cooperate with each other during contingencies. The defense ministry estimates that North Korea has up to 5,000 tons of chemical weapons and is capable of growing cholera, smallpox and anthrax.
Han addressed concerns that South Korea's Guided Weapons Defense Command may be vulnerable to missiles from North Korea, saying that the unit's armory and ammunition chamber will be well protected.
"Developments of mid-range surface-to-air missiles (M-SAM) and long-range surface-to-air missiles (L-SAM), which will be used in missile defense, have been included in the mid-term defense plans," Han said, according to Yonhap News Agency. "I think they may take five to 10 years to develop."